The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4330794 4117288 F 1 4330794-5 20040309 20040310 20040331 EXP USA040361710 ELI LILLY AND COMPANY 40 YR F N 20040324

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4330794 1004757102 PS STRATTERA 1 100 MG DAY D 7EE89B 20050701 21411
4330794 1004765368 C LITHIUM 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
4330794 1004757102 ATTENTION DEFICIT/HYPERACTIVITY DISORDER

Outcome of event

Event ID OUTC COD
4330794 HO

Reactions reported

Event ID PT
4330794 CHEST PAIN
4330794 GASTROOESOPHAGEAL REFLUX DISEASE
4330794 HYPERHIDROSIS

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4330794 CSM

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4330794 1004757102 20031201